Published in BMC Infect Dis on March 13, 2014
Partial Oral Antimicrobials to Treat Infective Endocarditis in People Who Inject Drugs | NCT04544306
Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients. Can J Hosp Pharm (2015) 0.81
A mini review on pyridoacridines: Prospective lead compounds in medicinal chemistry. J Adv Res (2014) 0.80
Managing infective endocarditis in the elderly: new issues for an old disease. Clin Interv Aging (2016) 0.75
Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges. IEEE Trans Nanobioscience (2016) 0.75
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Infective endocarditis in adults. N Engl J Med (2001) 9.95
Amoxycillin: a new semi-synthetic penicillin. Br Med J (1972) 5.57
Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother (1972) 2.35
Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet (1989) 2.18
Infective endocarditis. Nat Rev Cardiol (2011) 1.77
Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.70
Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med (1992) 1.69
The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis. J Antimicrob Chemother (1987) 1.69
Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1989) 1.64
ORAL TREATMENT OF BACTERIAL ENDOCARDITIS WITH PENICILLINS. Lancet (1964) 1.63
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1997) 1.58
How to read clinical journals: III. To learn the clinical course and prognosis of disease. Can Med Assoc J (1981) 1.48
The newer fluoroquinolones. Infect Dis Clin North Am (2009) 1.44
The choice of antibiotic for treating infective endocarditis. Q J Med (1975) 1.40
Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob Agents Chemother (2002) 1.32
Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. J Antimicrob Chemother (2011) 1.25
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med (1996) 1.18
Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1994) 1.04
Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis. J Infect Dis (1991) 1.03
Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits. Rev Infect Dis (1983) 1.03
Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis. Antimicrob Agents Chemother (2005) 1.03
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrob Agents Chemother (2004) 1.01
Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis. J Infect Dis (2003) 1.00
Treatment of prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus with minocycline. J Infect Dis (1990) 0.99
Oral antibiotic therapy of serious systemic infections. Med Clin North Am (2006) 0.97
Oral treatment of subacute bacterial endocarditis in children. Arch Dis Child (1977) 0.93
Treatment of severe staphylococcal infections with a rifampicin-minocycline association. J Antimicrob Chemother (1984) 0.88
Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model. Clin Infect Dis (2001) 0.88
Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. Antimicrob Agents Chemother (2000) 0.84
Treatment of subacute bacterial endocarditis with aureomycin. J Am Med Assoc (1952) 0.83
Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis (1991) 0.82
Treatment of Staphylococcus aureus endocarditis using moxifloxacin. Int J Med Microbiol (2001) 0.80
Phenoxymethylpenicillin (penicillin V) and phenethicillin. Med Clin North Am (1970) 0.80
Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter. Fundam Clin Pharmacol (2008) 0.78
Partial oral treatment of endocarditis. Am Heart J (2013) 0.77
High-dose oral amoxycillin in the treatment of infective endocarditis. S Afr Med J (1988) 0.77
Oral treatment of bacterial endocarditis. Isr J Med Sci (1983) 0.77
Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness. Int J Antimicrob Agents (2010) 0.77
The absorption and distribution of aureomycin in man; a review of the literature and study of the concentration of aureomycin in the serum, urine and cerebrospinal fluid after oral administration. Ann Intern Med (1954) 0.77
Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents (2008) 0.76
[Oral treatment of malignant streptococcal endocarditis by potassium phenethicillin: 10 cases]. Union Med Can (1963) 0.76
The use of beta-lactam antibiotics in the treatment of septicaemia and endocarditis. Scand J Infect Dis Suppl (1984) 0.76
Evaluation of new anti-infective drugs for the treatment of infective endocarditis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.76
Methicillin-sensitive Staphylococcus aureus tricuspid valve endocarditis with annular abscess cured with oral levofloxacin and rifampicin. Int J Antimicrob Agents (2007) 0.76
Comparative bioavailability study of two phenoxymethylpenicillin potassium tablet formulations in healthy volunteers. Int J Clin Pharmacol Ther (2007) 0.76
Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis. Ann Thorac Surg (2007) 0.76
Enhanced turbulence and energy dissipation at ocean fronts. Science (2011) 2.76
Eddy-driven stratification initiates North Atlantic spring phytoplankton blooms. Science (2012) 2.11
Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother (2006) 2.05
Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed. AIDS (2007) 1.85
Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med (2007) 1.75
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults. AIDS (2005) 1.68
Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med (2011) 1.42
Sex, politics, and religion: why AIDS is a secular issue. J Int Assoc Physicians AIDS Care (Chic) (2004) 1.40
Twenty-five years of AIDS. CMAJ (2006) 1.39
The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. Clin Pharmacol Ther (2004) 1.33
Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis (2005) 1.32
Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis (2002) 1.30
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. Vaccine (2004) 1.23
Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet (2010) 1.21
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J Acquir Immune Defic Syndr (2009) 1.19
Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis (2006) 1.07
Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS (2002) 1.05
Time-dependent interaction between lopinavir/ritonavir and fexofenadine. J Clin Pharmacol (2006) 1.02
Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence. Clin Dev Immunol (2012) 0.99
Development and validation of the HIV Medication Readiness Scale. Assessment (2007) 0.97
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use. AIDS (2006) 0.97
The role of psychological and behavioral variables in quality of life and the experience of bodily pain among persons living with HIV. J Pain Symptom Manage (2008) 0.97
A 7-year retrospective review from 2005 to 2011 of Propionibacterium acnes shoulder infections in Ottawa, Ontario, Canada. Diagn Microbiol Infect Dis (2012) 0.95
Systematic review of the effectiveness of training programs in writing for scholarly publication, journal editing, and manuscript peer review (protocol). Syst Rev (2013) 0.95
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. Emerg Infect Dis (2016) 0.94
Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia. Clin Infect Dis (2006) 0.91
Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review. Transfusion (2005) 0.88
Inhibition of human cytochrome p450 metabolism by blended herbal products and vitamins. J Pharm Pharm Sci (2011) 0.87
Connection domain mutations in treatment-experienced patients in the OPTIMA trial. J Acquir Immune Defic Syndr (2010) 0.85
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial. PLoS One (2011) 0.82
Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA). J Chemother (2015) 0.82
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada. Chest (2015) 0.81
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease. J Acquir Immune Defic Syndr (2013) 0.80
Health of prisoners, and the public health: no man is an island. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.80
High HIV knowledge relates to low stigma in pharmacists and university health science students in Guyana, South America. Int J Infect Dis (2010) 0.79
Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. J Immunol Methods (2005) 0.79
In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi. J Antimicrob Chemother (2005) 0.79
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial. Med Decis Making (2011) 0.79
Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis. Chest (2007) 0.78
Interaction studies of tipranavir-ritonavir with clarithromycin, fluconazole, and rifabutin in healthy volunteers. Antimicrob Agents Chemother (2008) 0.78
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal. PLoS One (2011) 0.78
Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection. AIDS (2004) 0.78
Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection. Contemp Clin Trials (2010) 0.78
Serological diagnosis of syphilis: enzyme-linked immunosorbent assay to measure antibodies to individual recombinant Treponema pallidum antigens. J Immunoassay Immunochem (2008) 0.78
Tuberculosis elimination in the Canadian First Nations population: assessment by a state-transfer, compartmental epidemic model. Int J Infect Dis (2009) 0.77
Use of signature-tagged mutagenesis to identify virulence determinants in Haemophilus ducreyi responsible for ulcer formation. J Microbiol Methods (2010) 0.77
Effect of resveratrol on exercise capacity: a randomized placebo-controlled crossover pilot study. Appl Physiol Nutr Metab (2014) 0.76
Intra-aortic balloon pump in patients with cardiogenic shock complicating myocardial infarction: a systematic review and meta-analysis of randomized trials (protocol). Syst Rev (2014) 0.75
Antidepressant prophylaxis reduces depression risk but does not improve sustained virological response in hepatitis C interferon recipients without depression at baseline: a systematic review and meta-analysis. Can J Gastroenterol (2013) 0.75
The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model. BMC Pediatr (2006) 0.75
Pharmaceutical gifts of medicine. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.75
On the zoonosis of M. avium subspecies paratuberculosis (MAP). J Crohns Colitis (2012) 0.75
After terror, more horrors of war. J Int Assoc Physicians AIDS Care (Chic) (2002) 0.75
A bio-inspired kinematic controller for obstacle avoidance during reaching tasks with real robots. Neural Netw (2012) 0.75
Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med (2017) 0.75
Epidemic HIV-associated Kaposi's sarcoma: not as common as it used to be. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.75
The case for case reports. Int J Infect Dis (2010) 0.75
Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med (2017) 0.75
Common dermatologic manifestations of herpesviruses in HIV/AIDS. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.75
Oral immunization using HgbA in a recombinant chancroid vaccine delivered by attenuated Salmonella typhimurium SL3261 in the temperature-dependent rabbit model. J Immunol Methods (2011) 0.75
Intraaortic balloon pump in patients with cardiogenic shock complicating myocardial infarction: a systematic review and meta-analysis of randomized trials. Pol Arch Med Wewn (2015) 0.75
Needs and prospects for HIV therapy in developing countries. J Int Assoc Physicians AIDS Care (Chic) (2002) 0.75
Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodies. Clin Infect Dis (2002) 0.75
Identification and characterization of a heme periplasmic-binding protein in Haemophilus ducreyi. Biometals (2011) 0.75
Mouse viruses and human disease. Lancet Infect Dis (2011) 0.75
"Au Revoir les Enfants" without leadership for HIV treatment in poor countries. J Int Assoc Physicians AIDS Care (Chic) (2003) 0.75